Literature DB >> 8474448

The product of the EMS1 gene, amplified and overexpressed in human carcinomas, is homologous to a v-src substrate and is located in cell-substratum contact sites.

E Schuuring1, E Verhoeven, S Litvinov, R J Michalides.   

Abstract

We have previously identified two genes (EMS1 and PRAD1/cyclin D1) in the chromosome 11q13 region that are frequently coamplified and overexpressed in human breast cancer and in squamous cell carcinomas of the head and neck (E. Schuuring, E. Verhoeven, W.J. Mooi, and R.J.A.M. Michalides, Oncogene 7:355-361, 1992). We now report on the characterization of the 80/85-kDa protein that is encoded by the EMS1 gene. Amino acid sequence comparison shows a high homology (85%) to a chicken protein that was recently identified as a substrate for the src oncogene (H. Wu, A.B. Reynolds, S.B. Kanner, R.R. Vines, and J.T. Parsons, Mol. Cell. Biol. 11:5113-5124, 1991). Immunocytochemistry reveals that in epithelial cells, the human EMS1 protein is localized mainly in the cytoplasm and, to a very low extent, in protruding leading lamellae of the cell. However, in carcinoma cells that constitutively overexpress the protein as a result of amplification of the EMS1 gene, the protein, except in cytoplasm, accumulates in the podosome-like adherens junctions associated with the cell-substratum contact sites. The protein was not found in intercellular adherens junctions. Our findings, and the previously reported observations in src-transformed chicken embryo fibroblasts, suggest that the EMS1 protein is involved in regulating the interactions between components of adherens-type junctions. Since amplification of the 11q13 region has been associated with an enhanced invasive potential of these tumors, overexpression and concomitant accumulation of the EMS1 protein in the cell-substratum contact sites might, therefore, contribute to the invasive potential of these tumor cells.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8474448      PMCID: PMC359682          DOI: 10.1128/mcb.13.5.2891-2898.1993

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  45 in total

1.  Identification and characterization of a novel cytoskeleton-associated pp60src substrate.

Authors:  H Wu; A B Reynolds; S B Kanner; R R Vines; J T Parsons
Journal:  Mol Cell Biol       Date:  1991-10       Impact factor: 4.272

2.  Isolation and characterization of a novel human gene expressed specifically in the cells of hematopoietic lineage.

Authors:  D Kitamura; H Kaneko; Y Miyagoe; T Ariyasu; T Watanabe
Journal:  Nucleic Acids Res       Date:  1989-11-25       Impact factor: 16.971

3.  PRAD1, a candidate BCL1 oncogene: mapping and expression in centrocytic lymphoma.

Authors:  C L Rosenberg; E Wong; E M Petty; A E Bale; Y Tsujimoto; N L Harris; A Arnold
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-01       Impact factor: 11.205

4.  Cell/substratum adhesions in RSV-transformed rat fibroblasts.

Authors:  M V Nermut; P Eason; E M Hirst; S Kellie
Journal:  Exp Cell Res       Date:  1991-04       Impact factor: 3.905

5.  Human D-type cyclin.

Authors:  Y Xiong; T Connolly; B Futcher; D Beach
Journal:  Cell       Date:  1991-05-17       Impact factor: 41.582

6.  A novel cyclin encoded by a bcl1-linked candidate oncogene.

Authors:  T Motokura; T Bloom; H G Kim; H Jüppner; J V Ruderman; H M Kronenberg; A Arnold
Journal:  Nature       Date:  1991-04-11       Impact factor: 49.962

7.  Colony-stimulating factor 1 regulates novel cyclins during the G1 phase of the cell cycle.

Authors:  H Matsushime; M F Roussel; R A Ashmun; C J Sherr
Journal:  Cell       Date:  1991-05-17       Impact factor: 41.582

8.  Characterization of a candidate bcl-1 gene.

Authors:  D A Withers; R C Harvey; J B Faust; O Melnyk; K Carey; T C Meeker
Journal:  Mol Cell Biol       Date:  1991-10       Impact factor: 4.272

9.  Isolation of three novel human cyclins by rescue of G1 cyclin (Cln) function in yeast.

Authors:  D J Lew; V Dulić; S I Reed
Journal:  Cell       Date:  1991-09-20       Impact factor: 41.582

10.  Specific proto-oncogenic tyrosine kinases of src family are enriched in cell-to-cell adherens junctions where the level of tyrosine phosphorylation is elevated.

Authors:  S Tsukita; K Oishi; T Akiyama; Y Yamanashi; T Yamamoto; S Tsukita
Journal:  J Cell Biol       Date:  1991-05       Impact factor: 10.539

View more
  48 in total

1.  Association of mouse actin-binding protein 1 (mAbp1/SH3P7), an Src kinase target, with dynamic regions of the cortical actin cytoskeleton in response to Rac1 activation.

Authors:  M M Kessels; A E Engqvist-Goldstein; D G Drubin
Journal:  Mol Biol Cell       Date:  2000-01       Impact factor: 4.138

Review 2.  Cortactin in cell migration and cancer at a glance.

Authors:  Stacey M MacGrath; Anthony J Koleske
Journal:  J Cell Sci       Date:  2012-04-01       Impact factor: 5.285

3.  Synergistic effect of EMS1-shRNA and sorafenib on proliferation, migration, invasion and endocytosis of SMMC-7721.

Authors:  Jiaming Zhou; Li Chen; Yixin Zhang; Yuanyuan Wu; Guilan Wang; Song He; Zhongying Guo; Yingze Wei
Journal:  J Mol Histol       Date:  2013-10-15       Impact factor: 2.611

4.  Src tyrosyl phosphorylates cortactin in response to prolactin.

Authors:  Alan Hammer; Sneha Laghate; Maria Diakonova
Journal:  Biochem Biophys Res Commun       Date:  2015-06-01       Impact factor: 3.575

Review 5.  SH2 domain-containing signaling proteins in human breast cancer.

Authors:  R J Daly
Journal:  Breast Cancer Res Treat       Date:  1995-04       Impact factor: 4.872

6.  Induction of mammary epithelial hyperplasias and mammary tumors in transgenic mice expressing a murine mammary tumor virus/activated c-src fusion gene.

Authors:  M A Webster; R D Cardiff; W J Muller
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-15       Impact factor: 11.205

7.  A new role for cortactin in invadopodia: regulation of protease secretion.

Authors:  Emily S Clark; Alissa M Weaver
Journal:  Eur J Cell Biol       Date:  2008-03-14       Impact factor: 4.492

8.  Cortactin phosphorylated by ERK1/2 localizes to sites of dynamic actin regulation and is required for carcinoma lamellipodia persistence.

Authors:  Laura C Kelley; Karen E Hayes; Amanda Gatesman Ammer; Karen H Martin; Scott A Weed
Journal:  PLoS One       Date:  2010-11-04       Impact factor: 3.240

9.  The actin-binding domain of cortactin is dynamic and unstructured and affects lateral and longitudinal contacts in F-actin.

Authors:  Alexander Shvetsov; Emir Berkane; David Chereau; Roberto Dominguez; Emil Reisler
Journal:  Cell Motil Cytoskeleton       Date:  2009-02

10.  Amplification and overexpression of the EMS 1 oncogene, a possible prognostic marker, in human hepatocellular carcinoma.

Authors:  Bao-Zhu Yuan; Xiaoling Zhou; Drazen B Zimonjic; Marian E Durkin; Nicholas C Popescu
Journal:  J Mol Diagn       Date:  2003-02       Impact factor: 5.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.